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Abstract
Background: Extramedullary myelomas (plasmacytoma) are malignant proliferations of plasma
cells in the absence of bone involvement. When they occur in the soft tissue they usually involve
the upper respiratory tract and oral cavity. Extramedullary plasmacytomas of breast are
uncommon.
Case presentation: A 70 year-old woman with bilateral breast masses underwent excisional
biopsy for suspected primary carcinoma that subsequently proved to be a recurrence from
extramedullary plasmacytoma of the mediastinum. This was diagnosed and treated 5-years prior to
appearance of breast lumps.
Conclusion: Though uncommon, considering the possibility of metastatic carcinoma and primary,
secondary or recurrent lymphoproliferative disease presenting as a breast mass may avoid
unnecessary surgeries.
Background
Extramedullary myelomas (plasmacytoma) are malignant
proliferations of plasma cells in the absence of bone
involvement. When occur in the soft tissue, it usually
involve the upper respiratory tract and oral cavity [1].
Plasmacytomas of breast are very rare.
This report describes a patient with bilateral breast masses
who underwent excision biopsy for suspected primary car-
cinoma that subsequently proved to be a recurrence from
extramedullary plasmacytoma of mediastinum treated 5
years ago. To the best of our knowledge, this is the first
case report of bilateral recurrence of a primary extramed-
ullary plasmacytoma in breast tissues after a long disease-
free interval.
Case presentation
A 70 year-old woman with a one-month history of bilat-
eral breast masses was referred to our cancer center for sur-
gical evaluation. There was no associated breast pain, skin
change or nipple discharge. There was no history of bone
pain, weight loss, fatigue, fever or other systemic com-
plaints and no family history of breast cancer. Significant
past medical history included treatment for an extramed-
ullary retrosternal plasmacytoma 5-years prior this
admission.
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At the time of the initial work-up for the retrosternal mass,
immunoelectrophoresis showed no evidence for hyper-
proteinemia or paraproteinemia. Whole body bone scan
was negative and a bone marrow biopsy revealed less than
5% of plasma cells. Therefore, multiple myeloma was
excluded by nuclear medicine, laboratory and histology
studies. The patient underwent radiation therapy (40 Gy
with fraction size of 200 cGy delivered over 4 weeks) fol-
lowed by chemotherapy with cyclophosphamide, cispla-
tin and prednisolone. The patient was followed by
laboratory tests, chest roentgenography, and computed
tomography annually. A bone scintigraphy was carried
out after 2 years and showed no uptake patient was there-
after lost to follow-up.
Five years after initial diagnosis of extramedullary plasma-
cytoma the patient presented with bilateral breast masses.
Physical examination revealed a 3.5 cm × 2.5 cm, mass in
the upper inner quadrant of the right breast and a similar
5.0 cm × 4.5 cm mass in the lower inner quadrant of the
left breast. No asymmetry, skin dimpling or signs of
inflammation were present. There was no axillary or supr-
aclavicular lymphadenopathy.
Mammography confirmed a well-defined 3.2 cm oval-
shaped mass in the upper inner quadrant of the right
breast, and a lobulated 5.5 cm density in lower inner
quadrant of the left breast without any tissue distortion,
inflammation and fibrotic reaction.(Figure 1) There were
no microcalcification and satellite lesions. These masses
were solid and hypoechoeic with multiple septations in
sonography.
Excisional biopsy of the masses revealed a 5.0 (left) and
3.0 (right) well-defined, capsulated gritty mass sur-
rounded by normal breast tissue. There was no extension
from the capsulated masses to pectoral muscles or chest
wall. Histopathological examination showed high-grade
tumors composed of immature and mature plasma cells.
Mitosis, necrosis, nuclear pleomorphism and binucleated
and multinucleated plasma cells were seen. (Figure 2)
Additional studies such as serum protein electrophoresis
and immunoelectrophoresis were normal. No Bence
Jones or other M components were detected in the urine.
Skeletal surveys (Tc99 bone scan and skull and pelvic X-
rays) did not show any pathological changes. There was
no evidence of anemia, hypercalcemia or renal insuffi-
ciency. However, the patient refused a second bone mar-
row biopsy.
Immunohistochemical studies were performed on the
paraffin embedded tissues to determine if the infiltrate
had monoclonal character. The tumor cells were diffusely
and strongly positive for lambda chains but negative for
kappa chains. (Figure 3)
The tumor cells were weakly positive for monoclonal
mouse anti human placental V538C, and plasma cell
markers (CD138). Nuclear prognostic marker (Ki67)
showed 50% to 80% nuclear expression indicative of high
proliferative activity and suggesting a plasmacytic tumor
with anaplastic components (Figure 4). Other immuno-
histochemical stains including CD21, cytokeratin, S100,
and HMB45 were negative.
A retrospective microscopic review of the mediastinal
mass showed similar morphology to the breast tumor.
Hence, the histological diagnosis of recurrent plasmacy-
toma was made.
Mammography of the patients' breasts (A: mediolateral  oblique, view B: craniocaudal view) Figure 1
Mammography of the patients' breasts (A: mediolateral 
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The patient was treated with oral Melfalan and Pred-
nisone. The patient has been disease free for twenty
months after treatment and has showed no evidence of
recurrence in the mediastinum, breast or any other region.
Discussion
Primary soft tissue extramedullary plasmacytoma (SEP) is
uncommon and is defined as a malignant tumor of
plasma cells arising in the soft tissue in the absence of
bone involvement. It can occur in any organ as a solitary
form of plasma cell neoplasm [2]. Although SEP can arise
throughout the body, almost 90% of the cases arise in the
head and neck areas, most commonly in the upper respi-
ratory tract including the nasal cavity, para nasal sinuses,
oropharynx, salivary glands and larynx [3-7]. Several
other sites can rarely be involved, including testis, blad-
der, urethra, breast, ovary, lung, pleura, thyroid, orbit,
brain and skin tissues (1, 8–17). Approximately forty-five
cases of breast plasmacytoma have been reported in
published literature since 1928 (1, 2, 18–21). More than
half of the lesions were unilateral (66%), with the major-
ity of the cases occurring in the setting of multiple mye-
loma (77%) (1, 2, 18–20, 22).
When plasmacytoma originates from soft tissues, like the
case presented here, the disease is usually associated with
a relatively mild clinical behavior and long survival, sug-
gesting that it is a truly different disease entity compared
to other plasma cell tumors [23].
Dimopoulos et al (1999) reported that solitary extramed-
ullary (soft tissue) plasmacytomas (SEP) are less common
than solitary bone plasmocytoma (SBP), and have a better
prognosis as the majority can be cured by local radiother-
apy [24].
Liebross et al (1999) reported local recurrence rates of less
than 5% after radiotherapy [6]. Mayr et al (1990) noted
that the risk of distant relapse is more than 30%, which is
significantly less than that seen with SBP [25]. Progressive
disease may accrue as multiple myeloma, SBP or
involvement of lymph nodes, skin or subcutaneous tis-
sues. Its recurrence, if any, tends to be within 2–3 years of
initial diagnosis. The reported ten year survival rate is at
least 66% [3,7].
Involvement of the breast with SEP is uncommon and
may occur either as a solitary primary tumor or as evi-
dence of disseminated multiple myeloma [19]. Our
patient was referred with bilateral breast masses. In an
approach to a patient with bilateral breast masses, differ-
ential diagnosis includes: fibroadenomas, complex cysts,
metastasis, lymphoma, synchronous breast cancer, focal
fibrosis, fat necrosis, abscess, and phyllodes tumor [20].
Metastatic lesions of the breast from extramammary neo-
plasms are rare and in larger studies have been reported to
constitute 0.4 to 2% of all breast malignancies. The most
common are lymphomas and other tumors of hematolog-
ical origin [26]. The striking feature in this case was the
recurrence of an isolated plasmacytoma (which was
treated successfully five year prior) in both breasts. As
approximately 20% of patients who present with isolated
extramedullary plasmacytoma will eventually develop
multiple myeloma, close follow-up is strongly recom-
mended [1,22].
Our patient did not have any prior breast aspiration cytol-
ogy. There are many tumors, which may present with plas-
macytoid appearance on aspiration cytology. Tumors
such as small ductal carcinoma and lobular carcinoma of
breast, metastatic carcinoid, metastatic melanoma and
some lymphomas may represent with uncohesive group
of cells with eccentric nuclei resembling plasma cells.
Hence, a plasmacytoma (with anaplastic plasma cells)
may be readily mistaken for carcinoma (or other
undifferentiated neoplasm) not only clinically, but also
on cytological examination. This would justify excision
biopsy and the use of an extended immunohistochemical
panel to include such markers as cytokeratin and S-100 in
the assessments. To help the cytopathologist avoid misin-
terpretation, clinical history and presentation are
extremely helpful. Most of the errors in histopathology
and cytopathology diagnosis occur when pathologist is
not aware of medical history of the patient and unusual
clinical presentation.
This case emphasizes the importance of distinguishing a
plasmacytoma of the breast from primary mammary
Photomicrograph showing nuclear pleomorphism, binucle- ated and multinucleated plasma cells with enlarged nucleoli  (Hematoxylin & Eosin) Figure 2
Photomicrograph showing nuclear pleomorphism, binucle-
ated and multinucleated plasma cells with enlarged nucleoli 
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carcinomas and other benign lesions to avoid unnecessary
surgery and provide the appropriate treatment and adju-
vant therapy.
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